http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101058350-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55594 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-35 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-35 |
| filingDate | 2003-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101058350-B1 |
| titleOfInvention | Allergy vaccine composition, its production method and its use in the treatment of allergy |
| abstract | FIELD OF THE INVENTION The present invention relates to the field of immunology, particularly immuno-allergy, and in particular to adjuvant or carrier compounds capable of modulating the immune response to allergens. The technical objective of the present application is to use a bacterial protein containing liposome that converts an allergic response Th2 and IgE to a protector response Th1 when applied to an allergic individual, for therapeutic or prophylactic use, as well as for allergic individuals. To obtain pharmaceutical preparations that can prevent the development and development. The vaccine composition consists of protein-containing liposomes derived from Gram-negative bacteria coupled to allergens and may optionally include other adjuvant and antigen. Its preparation and two immunization schemes are disclosed.n n n n Allergens, allergic reactions Th2, IgE, protector reactions Th1, protein containing liposomes |
| priorityDate | 2002-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 167.